ArticleCureus2026
Unexpected Prolonged Apnea Following Succinylcholine in a Medically Complex Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prolonged apnea after succinylcholine should prompt consideration of impaired drug metabolism, including reduced butyrylcholinesterase activity, while other causes of delayed emergence are evaluated. We report a 69-year-old, 72.7-kg man with severe systemic illness and hypoalbuminemia who underwent esophagogastroduodenoscopy and colonoscopy under total intravenous general anesthesia. Induction included propofol, fentanyl, and succinylcholine 100 mg. Approximately two hours after the initial succinylcholine dose, the patient was extubated but developed profound ventilatory weakness, with a respiratory rate of approximately three breaths per minute, tidal volumes of approximately 30 mL, and inability to sustain a head lift. Four qualitative train-of-four responses were present without subjectively detectable fade; no quantitative ratio was available. Naloxone improved alertness but did not restore adequate ventilation. Emergency reintubation was performed with an additional 80 mg of succinylcholine. Head computed tomography demonstrated no acute intracranial abnormality, and the patient was transferred to the intensive care unit for supportive ventilation. Respiratory strength returned gradually, and definitive extubation occurred at 21:25, approximately five hours and 37 minutes after reintubation. The profound weakness documented before the second succinylcholine dose raised concern for a prolonged effect of the initial dose. Severe hypoalbuminemia and systemic illness supported possible acquired reduction in butyrylcholinesterase activity, although inherited deficiency could not be excluded. Because enzyme activity, dibucaine inhibition, genetic testing, and quantitative neuromuscular monitoring were not obtained, the diagnosis remained presumptive. This case emphasizes that four qualitative twitches do not establish adequate neuromuscular recovery and that persistent ventilatory failure after improved consciousness warrants continued evaluation for neuromuscular blockade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.